Prediagnostic toenail selenium and risk of bladder cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 11, 2002, Pages 1292-1297

  Zeegers, Maurice P A ^a   Goldbohm, R Alexandra ^b   Bode, Peter ^c   Van den Brandt, Piet A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; SELENIUM;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RISK; DIET; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; TISSUE LEVEL; TOE; TRANSITIONAL CELL CARCINOMA;

AGED; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; EATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NAILS; NETHERLANDS; PROSPECTIVE STUDIES; RISK FACTORS; SELENIUM; SEX FACTORS; SMOKING; STATISTICS; URINARY BLADDER NEOPLASMS; VITAMIN E;

EID: 0036845570     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer, 80: 827-841, 1999
2. Silverman, D. T., Hartge, P., Morrison, A. S., and Devesa, S. S. Epidemiology of bladder cancer. Hematol. Oncol. Clin. N. Am., 6: 1-30, 1992
3. Johansson, S. L., and Cohen, S. M. Epidemiology and etiology of bladder cancer. Semin. Surg. Oncol., 13: 291-298, 1997
4. Ross, R. K., Jones, P. A., and Yu, M. C. Bladder cancer epidemiology and pathogenesis. Semin. Oncol., 23: 536-545, 1996
5. Bladder Cancer. In: Food, Nutrition and the Prevention of Cancer: A Global Perspective, pp. 338-361. Menasha (USA): Banta Book Group, 1997
6. van der Meijden, A. P. M. Bladder cancer. Br. Med. J., 317: 1366-1369, 1998
7. Helzlsouer, K. J., Comstock, G. W., and Morris, J. S. Selenium, lycopene, α-tocopherol, β-carotene, retinol, and subsequent bladder cancer. Cancer Res., 49: 6144-6148, 1989
8. Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R. K., Hakama, M., Hakulinen, T., Peto, R., and Teppo, L. Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl. Cancer Inst. (Bethesda), 82: 864-868, 1990
9. Clark, L. C., Combs, G. F., Jr., Tumbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Jr., Park, H. K., Sanders, B. B., Jr., Smith, C. L., and Taylor, J. R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial. J. Am. Med. Assoc., 276: 1957-1963, 1996
10. Fan, A. M., and Kizer, K. W. Selenium: Nutritional, toxicologic and clinical aspects. West. J. Med., 153: 160-167, 1990
11. Virtamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J. K., and Karvonen, M. J. Serum selenium and risk of cancer. A prospective follow-up of nine years. Cancer (Phila.), 60: 145-148, 1987
12. Garland, M., Morris, J. S., Stampfer, M. J., Colditz, G. A., Spate, V. L., Baskett, C. K., Rosner, B., Speizer, F. E., Willett, W. C., and Hunter, D. J. Prospective study of toenail selenium and cancer among women. J. Natl. Cancer Inst. (Bethesda), 87: 497-505, 1995
13. Nomura, A., Heilbrun, L. K., Morris, J. S., and Stemmermann, G. N. Serum selenium and the risk of cancer, by specific sites: Case-control analysis of prospective data. J. Natl. Cancer Inst. (Bethesda), 79: 103-108, 1987
14. Barlow, W. E., Ichikawa, L., Rosner, D., and Izumi, S. Analysis of case-cohort designs. J. Clin. Epidemiol., 52: 1165-1172, 1999
15. van den Brandt, P. A., Goldbohm, R. A., van het Veer, P., Volovics, A., Hermus, R. J. J., and Sturmans, F. A large-scale prospective cohort study on diet and cancer in the Netherlands. J. Clin. Epidemiol., 43: 285-295, 1990
16. van den Brandt, P. A., Schouten, L. J., Goldbohm, R. A., Dorant, E., and Hunen, P. H. M. Development of a record linkage protocol for use in the Dutch cancer registry for epidemiological research. Int. J. Epidemiol., 19: 553-558, 1990
17. Goldbohm, R. A., van den Brandt, P. A., and Dorant, E. Estimation of the coverage of Dutch municipalities by cancer registries and PALGA based on hospital discharge data. Tijdschr. Soc. Gezond., 72: 80-84, 1994
18. van den Brandt, P. A., Goldbohm, R. A., van't Veer, P., Bode, P., Hermus, R. J., and Sturmans, F. Predictors of toenail selenium levels in men and women. Cancer Epidemiol. Biomark. Prev., 2: 107-112, 1993
19. Bode, P., and de Bruin, M. An automated system for activation analysis with short half-life radionuclides using a carbon fiber irradiation facility. J. Radioanal. Chem., 132: 365-375, 1987
20. Spyrou, N. M. Activation analysis. J. Radioanal. Chem., 61: 211-242, 1981
21. Volovics, A., and van den Brandt, P. A. Methods for the analyses of case-cohort studies. Biom. J., 2: 195-214, 1997
22. Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation, 2000
23. Barlow, W. E. Robust variance estimation for the case-cohort design. Biometrics, 50: 1064-1072, 1994
24. Lin, D. Y., and Ying, Z. Cox regression with incomplete covariate measurements. J. Am. Stat. Ass., 88: 1341-1349, 1993
25. Goldbohm, R. A., van den Brandt, P. A., Brants, H. A., van het Veer, P., Al, M., Sturmans, F., and Hermus, R. J. S. O. Validation of a dietary questionnaire used in large-scale prospective cohort study on diet and cancer. Eur. J. Clin. Nutr., 48: 253-265, 1994
26. Willett, W. C., Polk, B. F., Morris, J. S., Stampfer, M. J., Pressel, S., Rosner, B., Taylor, J. O., Schneider, K., and Hames, C. G. Prediagnostic serum selenium and risk of cancer. Lancet, 2: 130-134, 1983
27. van den Brandt, P. A., Goldbohm, R. A., van't Veer, P., Bode, P., Dorant, E., Hermus, R. J., and Sturmans, F. Toenail selenium levels and the risk of breast cancer. Am. J. Epidemiol., 140: 20-26, 1994
28. van den Brandt, P. A., van het Veer, P., and Goldbohm, R. A. A prospective cohort study on dietary fat and the risk of postmenopausal breast cancer. Cancer Res., 53: 75-82, 1993
29. Cohen, S. M. Urinary bladder carcinogenesis. Toxicol. Pathol., 26: 121-127, 1998
30. Mohandas, J., Marshall, J. J., Duggin, G. G., Horvath, J. S., and Tiller, D. J. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res., 44: 5086-5091, 1984
31. Patterson, R. E., White, E., Kristal, A. R., Neuhouser, M. L., and Potter, J. D. Vitamin supplements and cancer risk: The epidemiologic evidence. Cancer Causes Control, 8: 786-802, 1997
32. Salonen, J. T., Alfthan, G., Huttunen, J. K., and Puska, P. Association between serum selenium and the risk of cancer. Am. J. Epidemiol., 120: 342-349, 1984
33. van den Brandt, P. A., Goldbohm, R. A., van't Veer, P., Bode, P., Dorant, E., Hermus, R. J., and Sturmans, F. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res., 53: 4860-4865, 1993